TrialX Updates: Leadership Insights, Patients as Partners 2026, Global Patient Recruitment and More…

As we return from an energizing week at SCOPE 2026 in Orlando, one thing is clear: the industry conversation has evolved. The focus has shifted from experimentation to execution — from “Should we modernize?” to “How…

Rare Disease Awareness: Finding Tuberous Sclerosis Complex (TSC) Clinical Trials Through a Guided Search Experience

Rare Disease Day is observed every year on the last day of February. In the United States, a disease is considered rare (or orphan) when it affects fewer than 200,000 people. While each condition may impact…

TrialX at SCOPE 2026: Simplifying Patient Recruitment, Spotlighting Clinical Research Heroes — Coffee, Conversations & Key Insights

Team TrialX at SCOPE 2026: Sharib Khan (Co-founder & CEO), Wes Martz (Senior Director of Client Services), Beth Dickson (VP, Business Development), and Brandon Ramos (Sales Development Representative) SCOPE 2026 once again brought together leaders across…

World Cancer Day: 10 FDA-Approved Oncology Breakthrough Drugs of 2025 That Marked Major Advances in Cancer Care

Each year, nearly 20 million people worldwide are diagnosed with cancer, a number projected to rise sharply in the coming decades. For patients and families, a diagnosis often brings uncertainty, difficult treatment decisions, and limited options—particularly…